Ding Wenting - Aesthetic Medical ViceChairwoman CoFounder
| AIH Stock | USD 0.33 0 0.91% |
Insider
Ding Wenting is ViceChairwoman CoFounder of Aesthetic Medical Intl
| Age | 59 |
| Address | 1122 Nanshan Boulevard, Shenzhen, China, 518052 |
| Phone | 86 75 525 598065 |
| Web | https://ir.aihgroup.net |
Aesthetic Medical Management Efficiency
The company has Return on Asset of (0.0551) % which means that on every $100 spent on assets, it lost $0.0551. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (4.9208) %, meaning that it generated no profit with money invested by stockholders. Aesthetic Medical's management efficiency ratios could be used to measure how well Aesthetic Medical manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.07. The current Return On Capital Employed is estimated to decrease to -0.34. As of now, Aesthetic Medical's Intangibles To Total Assets are decreasing as compared to previous years. The Aesthetic Medical's current Fixed Asset Turnover is estimated to increase to 2.52, while Total Assets are projected to decrease to under 554.2 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| Kevin Blaylock | Medical Facilities | N/A | |
| LLB BECON | Ramsay Health Care | N/A | |
| Colleen Harris | Ramsay Health Care | 54 | |
| Martyn Roberts | Ramsay Health Care | 55 | |
| David Watson | Medical Facilities | 57 | |
| Michael Gremley | Nova Leap Health | N/A | |
| Kah Hong | Ramsay Health Care | 50 | |
| Andrew Jones | Ramsay Health Care | 49 | |
| Matthias Link | Fresenius SE Co | N/A | |
| Sara Hennicken | Fresenius SE Co | 43 | |
| Alison DeBlois | Nova Leap Health | N/A | |
| John Schario | Medical Facilities | N/A | |
| Michael Sen | Fresenius SE Co | 55 | |
| AC DSc | Ramsay Health Care | 70 | |
| Andrew Wearne | Ramsay Health Care | N/A | |
| William May | Medical Facilities | N/A | |
| Blake Curd | Medical Facilities | N/A | |
| Helen Giza | Fresenius SE Co | 55 | |
| Carla Kriwet | Fresenius SE Co | 51 | |
| Sebastian Biedenkopf | Fresenius SE Co | 59 | |
| Kelly Hibbins | Ramsay Health Care | N/A | |
Management Performance
| Return On Equity | -4.92 | ||||
| Return On Asset | -0.0551 |
Aesthetic Medical Intl Leadership Team
Elected by the shareholders, the Aesthetic Medical's board of directors comprises two types of representatives: Aesthetic Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aesthetic. The board's role is to monitor Aesthetic Medical's management team and ensure that shareholders' interests are well served. Aesthetic Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aesthetic Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Chen Zhang, Executive Board | ||
| Pengwu Zhou, Chairman CoFounder | ||
| Yitao Zhou, Chief Director | ||
| Ding Wenting, ViceChairwoman CoFounder | ||
| Guanhua Wu, Chief Officer | ||
| Derrick Shi, Investor Director | ||
| Qing Hu, Chief Officer |
Aesthetic Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aesthetic Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -4.92 | ||||
| Return On Asset | -0.0551 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | (0.11) % | ||||
| Current Valuation | 218.85 M | ||||
| Shares Outstanding | 47.79 M | ||||
| Shares Owned By Institutions | 0.93 % | ||||
| Number Of Shares Shorted | 294.37 K | ||||
| Price To Earning | 4.53 X | ||||
| Price To Book | 3.27 X |
Currently Active Assets on Macroaxis
| VWITX | Vanguard Intermediate Term Tax Exempt | |
| VGSTX | Vanguard Star Fund | |
| VFIAX | Vanguard 500 Index | |
| VTCLX | Vanguard Tax Managed Capital | |
| VTSAX | Vanguard Total Stock |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aesthetic Medical Intl. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Aesthetic Stock analysis
When running Aesthetic Medical's price analysis, check to measure Aesthetic Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aesthetic Medical is operating at the current time. Most of Aesthetic Medical's value examination focuses on studying past and present price action to predict the probability of Aesthetic Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aesthetic Medical's price. Additionally, you may evaluate how the addition of Aesthetic Medical to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |
Is Aesthetic Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aesthetic Medical. If investors know Aesthetic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aesthetic Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 12.19 | Earnings Share (0.12) | Revenue Per Share 15.554 | Quarterly Revenue Growth 0.105 | Return On Assets (0.06) |
The market value of Aesthetic Medical Intl is measured differently than its book value, which is the value of Aesthetic that is recorded on the company's balance sheet. Investors also form their own opinion of Aesthetic Medical's value that differs from its market value or its book value, called intrinsic value, which is Aesthetic Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aesthetic Medical's market value can be influenced by many factors that don't directly affect Aesthetic Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aesthetic Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aesthetic Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aesthetic Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.